According to the ANOVA analyses, MD subjects were found to have lower IL-1β concentration levels (1.23 ± 0.21 pg/mL) than MD+PSTD subjects (2.39 ± 0.41 pg/mL) [mean and standard deviation analysed with the significance level of = 0.05 for the MD group is shown in Table 1]. This evidence concerns the gene IL1B and Menkes disease.